3rd January 2024

BSAC is collaborating with the University of Aberdeen Epidemiology Group to develop the first UK Antimicrobial Registry (UKAR) to provide information about the safety and efficacy of new antimicrobials in real-world use. Why not get involved?

The UKAR Study aims to provide answers to some very important questions:

  • How widely are last-line antimicrobials being used across the UK?
  • Which patient groups are being prescribed these drugs?
  • Which infections the drugs are being used to treat and why these agents are selected for use?

Not only does it represent an important way to tackle antimicrobial resistance, it’s also a great way to get involved in research as the study is registered with the NIHR Associate Principal Investigator (PI) scheme.

The UKAR Study currently has five Associate PIs across UKAR Study recruiting centres across the UK. The Associate PI scheme is a six-month in-work training opportunity with mentorship from a PI of an NIHR portfolio study. The scheme is an excellent way for professionals, such as Pharmacists and Trainees from FY1 upwards, to gain practical experience of day-to-day clinical research. Responsibilities of an Associate PI include:

  1. Assisting the PI by ensuring the completion of GCP training by everyone on the local research team and maintaining local study documents.
  2. Regular engagement with the study team and with study activities such as screening for eligible patients, approaching potential participants and consenting them to the study.
  3. Presenting the study to colleagues to maximise engagement within relevant departments.
  4. Equality, Diversity And Inclusion In Health And Social Care Research Training.

Loads of information, How-to Guides and toolkits can be found on the NIHR API scheme web pages.

Dr Corrine Ashton, Lead Antimicrobial Pharmacist at the University Hospitals of Leicester NHS Trust has been an Associate PI on the UKAR Study for 3 months. Corrine had this to say about the scheme:

“The Associate PI Scheme has given me a brilliant opportunity to gain practical skills in research that I wouldn’t normally have gained in my usual day-to-day role; the experience has allowed me to explore how I embed research into my job in the future.  Undertaking the scheme with UKAR has blended seamlessly into my normal job and the hands-on experience, supported by the PI and research team, has really shown that I can be involved in research in a way that I hadn’t thought possible.”

For more information about how to get involved with the UKAR Study, contact the UKAR team (ukar@abdn.ac.uk), visit the UKAR study website or complete the UKAR Expression of Interest Form. The team will then get in touch to set up an informal Teams meeting to discuss the best way to run the study at your site.

11 UKAR eligible study drugs

  • Cefiderocol*
  • Ceftaroline
  • Ceftazidime/avibactam*
  • Ceftobiprole
  • Ceftolozane/tazobactam
  • Dalbavancin
  • Delafloxacin
  • Eravacycline
  • Imipenem/cilastatin/relebactam
  • Meropenem/vaborbactam
  • Oritavancin

*Antimicrobial agents in the NICE de-linkage initiative

GP? Pharmacist? Researcher? Social Scientist? Whatever field you work in, if you’re committed to fighting infection then we want you to join us as a BSAC Member.
Become a member

Having trouble finding what you're after?

Top